Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
Abstract Background To compare the efficacy and safety of postoperative extensive target volume irradiation with elevated radiation dose and concurrent chemotherapy with radiotherapy only for the postoperative treatment of esophageal squamous cell carcinoma. Methods This trial was a single-arm phase...
| Published in: | Radiation Oncology |
|---|---|
| Main Authors: | Dashan Ai, Yun Chen, Qi Liu, Jiaying Deng, Xiaofei Zhang, Junhua Zhang, Li Chu, Jingyi Shen, Longfei Ma, Yawei Zhang, Haiquan Chen, Longsheng Miao, Kuaile Zhao, Jiaqing Xiang |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-02-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13014-023-02211-w |
Similar Items
Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis
by: Jiaying Deng, et al.
Published: (2024-12-01)
by: Jiaying Deng, et al.
Published: (2024-12-01)
Analysis of clinical features, prognosis and comprehensive therapeutic strategies in 261 patients with limited-stage esophageal small cell carcinoma
by: LIU Di, NI Jianjiao, ZHAO Kuaile, XIANG Jiaqing, ZHANG Zhen, ZHANG Junhua
Published: (2025-05-01)
by: LIU Di, NI Jianjiao, ZHAO Kuaile, XIANG Jiaqing, ZHANG Zhen, ZHANG Junhua
Published: (2025-05-01)
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trialResearch in context
by: Dashan Ai, et al.
Published: (2024-03-01)
by: Dashan Ai, et al.
Published: (2024-03-01)
Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities
by: Yun Chen, et al.
Published: (2022-04-01)
by: Yun Chen, et al.
Published: (2022-04-01)
A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
by: Kazem Anvari, et al.
Published: (2015-01-01)
by: Kazem Anvari, et al.
Published: (2015-01-01)
Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy
by: Zongxing Zhao, et al.
Published: (2020-08-01)
by: Zongxing Zhao, et al.
Published: (2020-08-01)
Comparison of the Clinical Outcomes of Esophagectomy and Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
by: Myung Hun Lee, et al.
Published: (2024-03-01)
by: Myung Hun Lee, et al.
Published: (2024-03-01)
Clinical Factors to Predict the Response to Concurrent Chemoradiotherapy and Survival in Esophageal Cancer Patients
by: Su Youn Nam, et al.
Published: (2020-07-01)
by: Su Youn Nam, et al.
Published: (2020-07-01)
Prediction of esophageal fistula in radiotherapy/chemoradiotherapy for patients with advanced esophageal cancer by a clinical-deep learning radiomics model
by: Yuxin Zhang, et al.
Published: (2024-11-01)
by: Yuxin Zhang, et al.
Published: (2024-11-01)
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
by: Yoshitaka Honma, et al.
Published: (2020-01-01)
by: Yoshitaka Honma, et al.
Published: (2020-01-01)
Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma
by: Sakanaka K, et al.
Published: (2019-04-01)
by: Sakanaka K, et al.
Published: (2019-04-01)
Surgical tactics for esophageal cancer with complete pathomorphosis after chemoradiotherapy
by: B. V. Sigua, et al.
Published: (2024-10-01)
by: B. V. Sigua, et al.
Published: (2024-10-01)
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
by: Xi-Lei Zhou, et al.
Published: (2021-05-01)
by: Xi-Lei Zhou, et al.
Published: (2021-05-01)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01)
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01)
The treatment outcome of definitive chemoradiotherapy in patients with esophageal squamous cell carcinoma
by: Mahdi Seilanian Toosi, et al.
Published: (2007-10-01)
by: Mahdi Seilanian Toosi, et al.
Published: (2007-10-01)
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs
by: Ihsuan Tseng, et al.
Published: (2023-10-01)
by: Ihsuan Tseng, et al.
Published: (2023-10-01)
Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
by: Jiazhen Chen, et al.
Published: (2025-08-01)
by: Jiazhen Chen, et al.
Published: (2025-08-01)
The significance of consolidation chemotherapy after concurrent chemoradiotherapy in esophageal squamous cell carcinoma: a randomized controlled phase III clinical trial
by: Qingshan Zhu, et al.
Published: (2024-10-01)
by: Qingshan Zhu, et al.
Published: (2024-10-01)
Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics
by: Jie Yang, et al.
Published: (2025-03-01)
by: Jie Yang, et al.
Published: (2025-03-01)
Involved‐field high‐dose chemoradiotherapy with respiratory motion management for esophageal squamous cell carcinoma
by: Masaki Matsuda, et al.
Published: (2024-11-01)
by: Masaki Matsuda, et al.
Published: (2024-11-01)
Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
by: Guihong Liu, et al.
Published: (2024-03-01)
by: Guihong Liu, et al.
Published: (2024-03-01)
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
by: Chih-Yi Chen, et al.
Published: (2018-07-01)
by: Chih-Yi Chen, et al.
Published: (2018-07-01)
Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
by: Jae Kwang Yun, et al.
Published: (2022-10-01)
by: Jae Kwang Yun, et al.
Published: (2022-10-01)
Neoadjuvant chemoradiotherapy for thoracic esophageal squamous cell carcinoma: does everyone need it?
by: D. A. Chichevatov, et al.
Published: (2024-05-01)
by: D. A. Chichevatov, et al.
Published: (2024-05-01)
Therapeutic evaluation of postoperative chemotherapy and chemoradiotherapy on cardiopulmonary complications in patients with esophageal squamous cell carcinoma
by: Gustavo Martins Aransiola, et al.
Published: (2023-07-01)
by: Gustavo Martins Aransiola, et al.
Published: (2023-07-01)
Radical chemoradiotherapy for superficial esophageal cancer complicated with liver cirrhosis
by: Hejing Bao, et al.
Published: (2024-09-01)
by: Hejing Bao, et al.
Published: (2024-09-01)
Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial
by: Ke Zhang, et al.
Published: (2025-02-01)
by: Ke Zhang, et al.
Published: (2025-02-01)
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
by: Mingqiu Chen, et al.
Published: (2018-08-01)
by: Mingqiu Chen, et al.
Published: (2018-08-01)
A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
by: Arunima Gupta, et al.
Published: (2014-01-01)
by: Arunima Gupta, et al.
Published: (2014-01-01)
Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
by: Guozhen Yang, et al.
Published: (2024-05-01)
by: Guozhen Yang, et al.
Published: (2024-05-01)
Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
by: Qing Liu, et al.
Published: (2024-08-01)
by: Qing Liu, et al.
Published: (2024-08-01)
Neoadjuvant sintilimab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, phase 2 trial
by: Zhi Zhang, et al.
Published: (2022-10-01)
by: Zhi Zhang, et al.
Published: (2022-10-01)
Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma
by: Xiaofeng Duan, et al.
Published: (2025-01-01)
by: Xiaofeng Duan, et al.
Published: (2025-01-01)
Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
by: Renxian Xie, et al.
Published: (2024-01-01)
by: Renxian Xie, et al.
Published: (2024-01-01)
The CONUT score is prognostic in esophageal cancer treated with chemoradiotherapy
by: Metin Demir, et al.
Published: (2023-01-01)
by: Metin Demir, et al.
Published: (2023-01-01)
Influence of Chemoradiotherapy Strategies and Factors on the Five-Years Survival of Patients with Esophageal Cancer
by: Seyed Kazem Mirinezhad, et al.
Published: (2014-08-01)
by: Seyed Kazem Mirinezhad, et al.
Published: (2014-08-01)
Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of age
by: Shuhei Mayanagi, et al.
Published: (2024-07-01)
by: Shuhei Mayanagi, et al.
Published: (2024-07-01)
Clinical presentation vs endoscopy for an early diagnosis of eosinophilic esophagitis
by: Michele Di Stefano, et al.
Published: (2022-03-01)
by: Michele Di Stefano, et al.
Published: (2022-03-01)
EsoFLIP-assisted dilation for dysphagia in systemic sclerosis: Highlighting the role of multimodal esophageal evaluation
by: Chakraborty Subhankar, et al.
Published: (2025-09-01)
by: Chakraborty Subhankar, et al.
Published: (2025-09-01)
Retention Esophagitis as a Significant Clinical Predictor of Progression to Esophageal Cancer in Achalasia
by: Haewon Kim, et al.
Published: (2018-03-01)
by: Haewon Kim, et al.
Published: (2018-03-01)
Similar Items
-
Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis
by: Jiaying Deng, et al.
Published: (2024-12-01) -
Analysis of clinical features, prognosis and comprehensive therapeutic strategies in 261 patients with limited-stage esophageal small cell carcinoma
by: LIU Di, NI Jianjiao, ZHAO Kuaile, XIANG Jiaqing, ZHANG Zhen, ZHANG Junhua
Published: (2025-05-01) -
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trialResearch in context
by: Dashan Ai, et al.
Published: (2024-03-01) -
Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities
by: Yun Chen, et al.
Published: (2022-04-01) -
A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
by: Kazem Anvari, et al.
Published: (2015-01-01)
